-
Telix Pharma (TLX) Makes Progress With New Study
17 Dec 2025 04:59 GMT
… On this front, Telix Pharmaceuticals Limited (NASDAQ:TLX) … and according to Telix Pharmaceuticals Limited (NASDAQ:TLX), … agent. Telix Pharmaceuticals Limited (NASDAQ:TLX)’s third-quarter financial report … increased its fiscal 2025 revenue guidance to $820 …
-
DAVIDsTEA Reports Third Quarter Results
16 Dec 2025 12:00 GMT
… 1% increase compared to Q3 2024, underscoring the … returning to sustained, profitable growth.” “The third quarter reflected the benefits … DAVIDsTEA entered into a revenue-linked financing agreement under … 000 grocery stores and pharmacies, over 1,500 …
-
Pfizer shares drop 5% with 2026 revenue projection and long-range outlook
16 Dec 2025 18:32 GMT
… , Pfizer is forecasting its 2026 revenue to be in the range … from this year’s estimated revenue of $62 billion—which the … $6-plus in 2028—the drugmaker said that it doesn’t … . is an “anomaly.”
In the third quarter, Pfizer’s numbers (PDF) were …
-
Netskope, Inc. Class A Common Stock (NASDAQ:NTSK) Q3 2026 Earnings Call Transcript
16 Dec 2025 13:10 GMT
… a Fortune 50 global pharmaceutical retailer that selected Netskope … third quarter, highlighted by accelerating growth in both ARR and revenue. … at the end of Q3. Total Q3 revenue grew 33% to … fiercely committed to delivering profitable growth. Thank you for …
-
ARDT STOCK DROP ALERT: Ardent Health, Inc. Revenue Drop Triggers Securities Investigation – Contact BFA Law if You Suffered Losses on Your Investment
15 Dec 2025 13:07 GMT
… 12, 2025, Ardent reported its Q3 2025 financial results. The Company … a $43 million decrease in revenue for the quarter. Ardent also … as $420 million from Teva Pharmaceutical Ind. Ltd. For more information …
-
Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead?
14 Dec 2025 23:09 GMT
Key Points
Shares of Teva Pharmaceutical Industries (NYSE: TEVA) … patent cliffs that branded-drug companies are constantly trying to … peers. When it reported third-quarter earnings, Teva beat Wall … data by YCharts.
Some drugmaker alternatives may be more …
-
The 7 Most Impactful M&A Deals of 2025
17 Dec 2025 05:22 GMT
… The small biopharma Madrigal Pharmaceuticals finally broke through with … billion acquisition of Gilgamesh Pharmaceuticals’ lead depression drug, … .7 million by the third quarter of 2023.
Gene therapy … bluebird’s assets into profits—including just selling the …
-
Dow Rises Over 100 Points; Lululemon Posts Upbeat Q3 Earnings
12 Dec 2025 14:59 GMT
… -than-expected results for the third quarter and raised its full-year … data from Benzinga Pro. Quarterly revenue of $2.57 billion beat … billion and was up from revenue of $2.4 billion from … to $0.11 after Cycle Pharmaceuticals announced plans to acquire the …
-
Samsung's Bio Units Surpass 100 Trillion Won Market Cap
17 Dec 2025 04:50 GMT
… sales among domestic pharmaceutical and bio companies. … global big pharma companies including Takeda Pharmaceutical, Gilead Sciences … third quarter this year.
Samsung Bioepis also succeeded in turning profitable … revenue from biosimilars. As global big pharma …
-
The Longevity Shift: Healthcare REITs to Benefit From Global Aging
17 Dec 2025 01:45 GMT
… if they focus only on pharma, biotech and medical devices … .
Per the company’s third-quarter 2025 earnings presentation, the … Omega is consistently showcasing increased revenues and improved operating metrics, … nearly $1 billion in revenue last quarter alone. A …